Infection risk with PI3K-AKT-mTOR pathway inhibitors and...

Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials

Fujiwara, Yutaka, Kuchiba, Aya, Koyama, Takafumi, Machida, Ryunosuke, Shimomura, Akihiko, Kitano, Shigehisa, Shimizu, Toshio, Yamamoto, Noboru
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2019-000653
Date:
April, 2020
File:
PDF, 467 KB
2020
Conversion to is in progress
Conversion to is failed